Alzheimer's amyloid immunotherapy: Quo vadis?

Sam Gandy, Frank L. Heppner

Research output: Contribution to journal › Letter › peer-review

11 Scopus citations

Access to Document

@article{7df3306546494f2a985b6edcf28dd098,

title = "Alzheimer's amyloid immunotherapy: Quo vadis?",

author = "Sam Gandy and Heppner, {Frank L.}",

year = "2005",

month = aug,

doi = "10.1016/S1474-4422(05)70124-1",

language = "English",

volume = "4",

pages = "452--453",

journal = "The Lancet Neurology",

issn = "1474-4422",

publisher = "Elsevier Ltd.",

number = "8",

}

TY - JOUR

T1 - Alzheimer's amyloid immunotherapy

T2 - Quo vadis?

AU - Gandy, Sam

AU - Heppner, Frank L.

PY - 2005/8

Y1 - 2005/8

UR - http://www.scopus.com/inward/record.url?scp=22144432331&partnerID=8YFLogxK

U2 - 10.1016/S1474-4422(05)70124-1

DO - 10.1016/S1474-4422(05)70124-1

M3 - Letter

C2 - 16033686

AN - SCOPUS:22144432331

SN - 1474-4422

VL - 4

SP - 452

EP - 453

JO - The Lancet Neurology

JF - The Lancet Neurology

IS - 8

ER -